Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Urologic Oncology|July 22, 2023
Racial and sex differences in tumor genomics in urothelial carcinomaYaw A Nyame, Kelsey K Baker, Bruce Montgomery, et al.
The Prostate|June 1, 2005
Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cellsR Bruce Montgomery, Michael Bonham, Peter S Nelson, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2011
Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)Christopher M Oermann, Karen S McCoy, George Z Retsch-Bogart, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Do statins affect androgen levels in men? Results from the Boston area community health surveySusan A Hall, Stephanie T Page, Thomas G Travison, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 31, 2019
A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary FibrosisJun Keng Khoo, A Bruce Montgomery, Kelly L Otto, et al.
American Journal of Respiratory and Critical Care Medicine|July 29, 2008
Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosisKaren S McCoy, Alexandra L Quittner, Christopher M Oermann, et al.
Cancer Research|November 26, 2009
Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progressionDiping Wang, R Bruce Montgomery, Lucy J Schmidt, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
The Journal of Urology|September 18, 2007
Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916R Bruce Montgomery, Bryan Goldman, Catherine M Tangen, et al.
Chemico-Biological Interactions|December 17, 2014
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancerDaniel Tamae, Elahe Mostaghel, Bruce Montgomery, et al.
Pageof 18